Heat therapy for leg pain from peripheral artery disease
Tests an 8 week heat therapy programme in people with intermittent claudication.
Key facts
- Who runs it
- Manchester Metropolitan University
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Heat Therapy and Peripheral Artery Disease
- Status
- Not yet recruiting
- People taking part
- 70 people, planned
- Started
- 1 May 2025
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Heat Therapy Intervention
- Record updated
- 14 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral artery disease who get leg pain when walking (intermittent claudication). It tests 8 weeks of heat therapy in a hot tub against usual care.
- Age
- Over 18 years.
- Sex
- All sexes can join.
- Disease stage
- Diagnosed intermittent claudication (leg pain on walking). ABPI (ankle-to-arm blood pressure ratio) below 0.9 at rest, or a drop of 20mmHG after exercise testing. Must be able to walk without help.
- Earlier treatment
- Must not be on hormone therapy unless post-menopausal. No recent or frequent heat exposure, such as sauna or hot tubs.
- Biomarker or test result
- ABPI < 0.9 at rest or a drop of 20mmHG after exercise testing.
Main reasons for not taking part
- Walking problems caused by something other than PAD
- Critical limb ischaemia or pain at rest, or PAD without symptoms
- Active cancer treatment
- Diagnosed diabetes or nerve damage in the limbs (peripheral neuropathy)
- Severe aortic stenosis, unstable angina, recent heart attack, stroke or TIA, or past fainting from heat
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- • Aged > 18 years; ABPI < 0.9 at rest or a drop of 20mmHG after exercise testing; Diagnosed with IC; Able to walk unaided; English-speaking and able to follow instructions; No previous history of heat syncope; Post-Menopausal or not on hormone therapy; Able to provide informed consent
Who cannot take part
- • Walking impairment for a reason other than PAD; Critical limb ischaemia/rest pain; Asymptomatic PAD; Active cancer treatment; Clinically diagnosed diabetes or those with peripheral neuropathy; Recent / frequent heat exposure (e.g., sauna or hot tubs); severe aortic stenosis, unstable angina, recent MI, stroke or TIA
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.
The 2 groups in the trial
- Wait-list controlNo study treatment, for comparison
Usual care 8 weeks
- Heat Therapy InterventionExisting treatment, for comparison
Heat therapy intervention through water submersion in a hot tub at \~40°C.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Heat Therapy for People with Peripheral Artery Disease: a Randomised Wait-List Controlled Feasibility Trial.
- Plain-language title
- Heat therapy for leg pain from peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 14 February 2025